Podcast Medicom Medical Publishers

EAU20 Virtual Congress - Highlights

July 22, 2020 Medicom Medical Publishers
Podcast Medicom Medical Publishers
EAU20 Virtual Congress - Highlights
Show Notes Chapter Markers

Summary of articles from the EAU20 Virtual Congress:

  1. Stolzenburg J-U, et al. Continence Following Robot-Assisted (R-LRPE) and Conventional Laparoscopic Radical Prostatectomy (LRPE) – Results of a Prospective, Randomized, Multicenter, Patient Blinded Study.
  2. Grimm MO, et al. Recurrent risk in patients with high grade non-muscle invasive bladder carcinoma in the randomized phase III clinical trial ‘NIMBUS’ stratified for EORTC and CUETO risk categories. A contemporary trend to less recurrences? 
  3. Shore N, et al. Results from the phase III study of nadofaregene firadenovec: Safety and efficacy in patients (pts) with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC). 
  4. Hofman M, et al. ProPSMA Study: a prospective randomised multi-centre study of PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy. 
  5. Barber N et al. Two year outcomes after aquablation compared to TURP: results from a blinded randomized trial.
  6. Josefsson AS, et al. A prospective randomised study of bicalutamide +/- docetaxel for non-metastatic prostate cancer with a rising PSA (SPCG-14).
  7. Tandoğdu Z et al. Urosepsis: Hot data from the SERPENS study.
Stolzenburg J-U, et al. Continence Following Robot-Assisted (R-LRPE) and Conventional Laparoscopic Radical Prostatectomy (LRPE) – Results of a Prospective, Randomized, Multicenter, Patient Blinded Study
Grimm MO, et al. Recurrent risk in patients with high grade non-muscle invasive bladder carcinoma in the randomized phase III clinical trial ‘NIMBUS’ stratified for EORTC and CUETO risk categories. A contemporary trend to less recurrences?
Shore N, et al. Results from the phase III study of nadofaregene firadenovec: Safety and efficacy in patients (pts) with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC).
Hofman M, et al. ProPSMA Study: a prospective randomised multi-centre study of PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy.
Barber N et al. Two year outcomes after aquablation compared to TURP: results from a blinded randomized trial.
Josefsson AS, et al. A prospective randomised study of bicalutamide +/- docetaxel for non-metastatic prostate cancer with a rising PSA (SPCG-14).
Tandoğdu Z et al. Urosepsis: Hot data from the SERPENS study.